Timber Pharmaceuticals, Inc. (TMBR) - Stock Prices, Stock Peers & Analysis

Home
TMBR

Company Name	Timber Pharmaceuticals, Inc.
Symbol	TMBR
Currency	USD
Price	1.461
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	5,014,890
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.2 - 3.39
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. John Koconis M.B.A.
Website	https://www.timberpharma.com

An error occurred while fetching data.

About Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a